Possible mechanisms and biomarkers of resistance to vismodegib in SHH medulloblastoma

Neuro Oncol. 2022 Jul 1;24(7):1210-1211. doi: 10.1093/neuonc/noac061.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Letter
  • Comment

MeSH terms

  • Anilides / pharmacology
  • Anilides / therapeutic use
  • Biomarkers
  • Cerebellar Neoplasms* / drug therapy
  • Hedgehog Proteins
  • Humans
  • Medulloblastoma* / drug therapy
  • Pyridines

Substances

  • Anilides
  • Biomarkers
  • Hedgehog Proteins
  • HhAntag691
  • Pyridines
  • SHH protein, human